Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND & AIMS A number of double, triple and quadruple therapies have been proposed as first line H. pylori infection empiric treatments. However, knowledge of their worldwide and regional comparative efficacy is lacking. We examined the comparative effectiveness of all empirically used first line regimens tested against standard triple treatment, using a network meta-analysis (NWM) of published RCTs. METHODS Data extracted from eligible RCTs were entered into a Bayesian NWM to investigate the comparative efficacy of H. pylori infection empiric first line regimens and to explore their effectiveness rank order. The ranking probability for each regimen, was evaluated by means of SUCRA (surfaces under cumulative ranking) values. RESULTS Sixty-eight eligible RCTs were included, giving a total of 92 paired comparisons with 22,975 patients, randomized to 8 first line regimens. The overall results showed that only vonoprazan triple therapy and reverse hybrid therapy achieved cure rates of more than 90%. Levofloxacin triple therapy performed best in Western countries (eradication rate 88.5%). The comparative effectiveness ranking showed that vonoprazan triple therapy had the best results, whereas standard triple therapy was the least efficacious regimen [SUCRA 92.4% vs 4.7% respectively, ORs (95% CrI 3.80(1.62-8.94)]. CONCLUSIONS For first line empiric H. pylori infection treatment, vonoprazan triple therapy and reverse hybrid therapy achieved high eradication rates of more than 90%. Levofloxacin triple therapy achieved the highest eradication rates in Western countries. Standard triple therapy was the least efficacious regimen in this NWM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
Salanti, G., Ades, A. E., & Ioannidis, J. P. A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.016 · Cited by 3,766
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Self-citationGraphical tools for network meta-analysis in STATA
Chaimani, A., Higgins, J. P. T., Mavridis, D., Spyridonos, P., & Salanti, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076654 · Cited by 2,473
Kyoto global consensus report on Helicobacter pylori gastritis
Sugano, K., Tack, J., Kuipers, E. J., Graham, D. Y., El-Omar, E. M., Miura, S., Haruma, K., Asaka, M., Uemura, N., & Malfertheiner, P. (2015) · Gut · doi:10.1136/gutjnl-2015-309252 · Cited by 1,876
Self-citationPuhan, M. A., Schunemann, H. J., Murad, M. H., Li, T., Brignardello-Petersen, R., Singh, J. A., Kessels, A. G., Guyatt, G. H., & for the GRADE Working Group (2014) · BMJ · doi:10.1136/bmj.g5630 · Cited by 1,812
Savoldi, A., Carrara, E., Graham, D. Y., Conti, M., & Tacconelli, E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.007 · Cited by 1,270
Self-citationHelicobacter pylori treatment in the era of increasing antibiotic resistance
Graham, D. Y., & Fischbach, L. (2010) · Gut · doi:10.1136/gut.2009.192757 · Cited by 1,028
Self-citationWhat is antimicrobial stewardship?
Dyar, O. J., Huttner, B., Schouten, J., & Pulcini, C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.026 · Cited by 870
Megraud, F., Coenen, S., Versporten, A., Kist, M., Lopez-Brea, M., Hirschl, A. M., Andersen, L. P., Goossens, H., Glupczynski, Y., & on behalf of the Study Group participants (2013) · Gut · doi:10.1136/gutjnl-2012-302254 · Cited by 839
Self-citationReview article: the global emergence of Helicobacter pylori antibiotic resistance
Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., & Valasek, M. A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13497 · Cited by 743
Malfertheiner, P., Bazzoli, F., Delchier, J.-C., Celiñski, K., Giguère, M., Rivière, M., & Mégraud, F. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60020-2 · Cited by 523
Self-citationLiou, J.-M., Malfertheiner, P., Lee, Y.-C., Sheu, B.-S., Sugano, K., Cheng, H.-C., Yeoh, K.-G., Hsu, P.-I., Goh, K.-L., Mahachai, V., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322368 · Cited by 493
Self-citationMurakami, K., Sakurai, Y., Shiino, M., Funao, N., Nishimura, A., & Asaka, M. (2016) · Gut · doi:10.1136/gutjnl-2015-311304 · Cited by 484
Vaira, D., Zullo, A., Vakil, N., Gatta, L., Ricci, C., Perna, F., Hassan, C., Bernabucci, V., Tampieri, A., & Morini, S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00006 · Cited by 266
Nyssen, O. P., Bordin, D., Tepes, B., Pérez-Aisa, Á., Vaira, D., Caldas, M., Bujanda, L., Castro-Fernandez, M., Lerang, F., Leja, M., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321372 · Cited by 264
Self-citationSequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication
(2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00002 · Cited by 262
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States
El-Serag, H. B., Kao, J. Y., Kanwal, F., Gilger, M., LoVecchio, F., Moss, S. F., Crowe, S., Elfant, A., Haas, T., Hapke, R. J., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.03.013 · Cited by 260
Self-citationGreenberg, E. R., Anderson, G. L., Morgan, D. R., Torres, J., Chey, W. D., Bravo, L. E., Dominguez, R. L., Ferreccio, C., Herrero, R., Lazcano-Ponce, E. C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60825-8 · Cited by 257
Influence of CYP2C19 Pharmacogenetic Polymorphism on Proton Pump Inhibitor-based Therapies
Furuta, T., Shirai, N., Sugimoto, M., Nakamura, A., Hishida, A., & Ishizaki, T. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.153 · Cited by 257
Laine, L. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)06010-0 · Cited by 240
Suzuki, S., Gotoda, T., Kusano, C., Ikehara, H., Ichijima, R., Ohyauchi, M., Ito, H., Kawamura, M., Ogata, Y., Ohtaka, M., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319954 · Cited by 239
High eradication rates of Helicobacter pylori with a new sequential treatment
Zullo, A., Vaira, D., Vakil, N., Hassan, C., Gatta, L., Ricci, C., De Francesco, V., Menegatti, M., Tampieri, A., Perna, F., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01461.x · Cited by 225
Brown, S., Hutton, B., Clifford, T., Coyle, D., Grima, D., Wells, G., & Cameron, C. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-110 · Cited by 209
Yang, J.-C., Lin, C.-J., Wang, H.-L., Chen, J.-D., Kao, J. Y., Shun, C.-T., Lu, C.-W., Lin, B.-R., Shieh, M.-J., Chang, M.-C., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.036 · Cited by 202
Liou, J.-M., Fang, Y.-J., Chen, C.-C., Bair, M.-J., Chang, C.-Y., Lee, Y.-C., Chen, M.-J., Chen, C.-C., Tseng, C.-H., Hsu, Y.-C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31409-x · Cited by 199
Katelaris, P. H., Forbes, G. M., Talley, N. J., & Crotty, B. (2002) · Gastroenterology · doi:10.1053/gast.2002.37051 · Cited by 160
Molina‐Infante, J., Pérez-Gallardo, B., Fernández‐Bermejo, M., Hernández-Alonso, M., Vinagre, G., Dueñas, C., Mateos-Rodríguez, J. M., González-García, G., Abadia, E. G., & Gisbert, J. P. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04274.x · Cited by 140
Self-citationLiou, J., Lin, J.-T., Chang, C.-Y., Chen, M., Cheng, T., Lee, Y., Chen, C.-J., Sheng, W., Wang, H., & Wu, M. (2010) · Gut · doi:10.1136/gut.2009.198309 · Cited by 118
Primary Antibiotic Resistance of Helicobacter pylori in China
Hu, Y., Zhu, Y., & Lü, N. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4536-8 · Cited by 117
Francesco, V. D., Zullo, A., Margiotta, M., Marangi, S., Burattini, O., Berloco, P. B., Russo, F., Barone, M., Leo, A. D., Minenna, M. F., et al. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2004.01818.x · Cited by 114
Rokkas, T., Gisbert, J. P., Niv, Y., & O’Morain, C. A. (2015) · United European Gastroenterology Journal · doi:10.1177/2050640615580889 · Cited by 110
Self-citationChen, Q., Long, X., Ji, Y., Liang, X., Li, D., Gao, H., Xu, B., Liu, M., Chen, Y., Sun, Y., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15273 · Cited by 96
Self-citationSchwartz, H., Krause, R. A., Sahba, B., Haber, M., Weissfeld, A. S., Rose, P. A., Siepman, N. Y., & Freston, J. W. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.169_b.x · Cited by 88
Kim, Y. S., Kim, S. J., Yoon, J. H., Suk, K. T., Kim, J. B., Kim, D. J., Kim, D. Y., Min, H.-J., Park, S. H., Shin, W. G., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04843.x · Cited by 78
Levofloxacin-Based Triple Therapy in First-Line Treatment for Helicobacter pylori Eradication
Nista, E. C., Candelli, M., Zocco, M. A., Cremonini, F., Ojetti, V., Finizio, R., Spada, C., Cammarota, G., Gasbarrini, A., & Gasbarrini, A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00716.x · Cited by 77
Self-citationTransitioning of Helicobacter pylori Therapy from Trial and Error to Antimicrobial Stewardship
Graham, D. Y. (2020) · Antibiotics · doi:10.3390/antibiotics9100671 · Cited by 76
Self-citationHsu, P., Wu, D., Chen, W., Tseng, H., Yu, H., Wang, H.-M., Kao, S., Lai, K., Chen, A., & Tsay, F. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02922-14 · Cited by 76
Rokkas, T., Gisbert, J. P., Gasbarrini, A., Hold, G. L., Tilg, H., Malfertheiner, P., Mégraud, F., & O’Morain, C. A. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619854587 · Cited by 75
Self-citationGraham, D. Y., Lü, H., & Shiotani, A. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15252 · Cited by 73
Self-citationMantzaris, G. J., Petraki, K., Archavlis, E. J., Amberiadis, P., Christoforidis, P., Kourtessas, D., Chiotakakou, E., & Triantafyllou, G. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200211000-00012 · Cited by 67
Chung, J., Jung, Y. K., Kim, Y. J., Kwon, K. A., Kim, J. H., Lee, J. J., Lee, S. M., Hahm, K. B., Lee, S., Jeong, J. Y., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07249.x · Cited by 66
Kim, B. J., Lee, H., Lee, Y. C., Jeon, S. W., Kim, G. H., Kim, H., Sung, J. K., Lee, D. H., Kim, H. U., Park, M. I., et al. (2019) · Gut and Liver · doi:10.5009/gnl19136 · Cited by 61
Georgopoulos, S. D., Xirouchakis, E., Martinez‐Gonzalez, B., Zampeli, E., Grivas, E., Spiliadi, C., Sotiropoulou, M. G., Petraki, K., Zografos, K., Laoudi, F., et al. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.04.011 · Cited by 48
Hung, I. F., Chan, P., Leung, S. S. M., Chan, F. S., Hsu, A. S. J., But, D. Y.-K., Seto, W., Wong, S. Y., Chan, C. K., Gu, Q., et al. (2009) · Helicobacter · doi:10.1111/j.1523-5378.2009.00722.x · Cited by 41
Seddik, H., Ahid, S., Adioui, T., Hamdi, F.-Z. E., Hassar, M., Abouqal, R., Cherrah, Y., & Benkirane, A. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1524-6 · Cited by 39
Tai, W., Liang, C., Lee, C., Chiu, C.-H., Hu, M., Lu, L., Kuo, Y., Kuo, C., Yen, Y., Kuo, C., et al. (2015) · BioMed Research International · doi:10.1155/2015/623732 · Cited by 37
Aminian, K., Farsad, F., Ghanbari, A., Fakhreih, S., & Hasheminasab, S. M. (2010) · PubMed · Cited by 35
Choi, K. H., Chung, W. C., Lee, K., Paik, C. N., Kim, E., Kang, B. K., Oak, J. H., & Jung, S. H. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.6.785 · Cited by 31
Özdil, K., Çalhan, T., Şahin, A., Şenateş, E., Kahraman, R., Yüzbaşıoğlu, B., Demirdağ, H., Demirsoy, H., & Sokmen, H. M. (2011) · Hepatogastroenterology · doi:10.5754/hge11075 · Cited by 28
Lee, J. Y., Kim, N., Park, K. S., Kim, H. J., Park, S. M., Baik, G. H., Shim, K., Oh, J. H., Choi, S. C., Kim, S. E., et al. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0490-8 · Cited by 20
Cited by
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Self-citationMalfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R., Schulz, C., Smith, S. I., & Suerbaum, S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00431-8 · Cited by 1,191
Self-citationACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey, W. D., Howden, C. W., Moss, S. F., Morgan, D. R., Greer, K. B., Grover, S., & Shah, S. C. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002968 · Cited by 419
Helicobacter pylori: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies
Ali, A., & AlHussaini, K. I. (2024) · Microorganisms · doi:10.3390/microorganisms12010222 · Cited by 162
“First introduced in 1989, such bezimadazole-derived acid suppressors are excellent healers of peptic ulcers and are given in combination with antibiotics in the treatment and eradication of H. pylori infections, which lead to exaggerated acid production in the infected individuals [125,126].”
Metadata
- Authors
- Rokkas, T., Gisbert, J. P., Malfertheiner, P., Niv, Y., Gasbarrini, A., Leja, M., Megraud, F., O’Morain, C., & Graham, D. Y.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 161
- Issue
- 2
- Pages
- 495-507.e4
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W3149792503
- Cited by
- 185
- References
- 52
- FWCI
- 28.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.